The GEPIA database showed that HDAC1/2/3/4/5/7/9/10/11 mRNA expression levels were significantly associated with glioma patient prognosis and could, therefore, be exploited as biomarkers for the prediction of glioma patient survival. Here, HDAC1 is linked to central nervous system cancer.